These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 3024302)
1. Inhibition of tumor development by dehydroepiandrosterone and related steroids. Schwartz AG; Pashko L; Whitcomb JM Toxicol Pathol; 1986; 14(3):357-62. PubMed ID: 3024302 [TBL] [Abstract][Full Text] [Related]
2. Dehydroepiandrosterone and 16 alpha-Br-epiandrosterone inhibit 12-O-tetradecanoylphorbol-13-acetate stimulation of superoxide radical production by human polymorphonuclear leukocytes. Whitcomb JM; Schwartz AG Carcinogenesis; 1985 Mar; 6(3):333-5. PubMed ID: 2983900 [TBL] [Abstract][Full Text] [Related]
3. Food restriction inhibits [3H] 7,12-dimethylbenz(a)anthracene binding to mouse skin DNA and tetradecanoylphorbol-13-acetate stimulation of epidermal [3H] thymidine incorporation. Schwartz AG; Pashko LL Anticancer Res; 1986; 6(6):1279-82. PubMed ID: 3101576 [TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone (DHEA) and 3 beta-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz[a]anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin papilloma formation in mice. Pashko LL; Rovito RJ; Williams JR; Sobel EL; Schwartz AG Carcinogenesis; 1984 Apr; 5(4):463-6. PubMed ID: 6231135 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of DNA synthesis in mouse epidermis and breast epithelium by dehydroepiandrosterone and related steroids. Pashko LL; Schwartz AG; Abou-Gharbia M; Swern D Carcinogenesis; 1981; 2(8):717-21. PubMed ID: 6456847 [TBL] [Abstract][Full Text] [Related]
7. Dehydroepiandrosterone and two structural analogs inhibit 12-O-tetradecanoylphorbol-13-acetate stimulation of prostaglandin E2 content in mouse skin. Hastings LA; Pashko LL; Lewbart ML; Schwartz AG Carcinogenesis; 1988 Jun; 9(6):1099-102. PubMed ID: 2967126 [TBL] [Abstract][Full Text] [Related]
8. Cancer chemoprevention with the adrenocortical steroid dehydroepiandrosterone and structural analogs. Schwartz AG; Pashko LL J Cell Biochem Suppl; 1993; 17G():73-9. PubMed ID: 8007713 [TBL] [Abstract][Full Text] [Related]
9. Modulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone. Gordon GB; Shantz LM; Talalay P Adv Enzyme Regul; 1987; 26():355-82. PubMed ID: 2960133 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-promoted skin tumor formation in mice by 16 alpha-fluoro-5-androsten-17-one and its reversal by deoxyribonucleosides. Pashko LL; Lewbart ML; Schwartz AG Carcinogenesis; 1991 Nov; 12(11):2189-92. PubMed ID: 1934309 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of macrophage superoxide generation by dehydroepiandrosterone. Mohan PF; Jacobson MS Am J Med Sci; 1993 Jul; 306(1):10-5. PubMed ID: 8392294 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of 7,12-dimethylbenz[a]anthracene-initiated and 12-O-tetradecanoylphorbol-13-acetate-promoted skin papilloma formation in mice by dehydroepiandrosterone and two synthetic analogs. Schwartz AG; Fairman DK; Polansky M; Lewbart ML; Pashko LL Carcinogenesis; 1989 Oct; 10(10):1809-13. PubMed ID: 2529051 [TBL] [Abstract][Full Text] [Related]
13. [Anti-mutagenicity activity of dehydroepiandrosterone]. Yang S; Fu Z; Wang F; Cao Y; Han R Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):137-40. PubMed ID: 12015034 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Trypanosoma brucei glucose-6-phosphate dehydrogenase by human steroids and their effects on the viability of cultured parasites. Cordeiro AT; Thiemann OH; Michels PA Bioorg Med Chem; 2009 Mar; 17(6):2483-9. PubMed ID: 19231202 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of 7,12-dimethylbenz[a]anthracene-induced lung tumorigenesis in A/J mice by food restriction is reversed by adrenalectomy. Pashko LL; Schwartz AG Carcinogenesis; 1996 Feb; 17(2):209-12. PubMed ID: 8625440 [TBL] [Abstract][Full Text] [Related]
16. Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side effects in mice and rats. Schwartz AG; Lewbart ML; Pashko LL Cancer Res; 1988 Sep; 48(17):4817-22. PubMed ID: 2970293 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the conversion of 3T3 fibroblast clones to adipocytes by dehydroepiandrosterone and related anticarcinogenic steroids. Gordon GB; Newitt JA; Shantz LM; Weng DE; Talalay P Cancer Res; 1986 Jul; 46(7):3389-95. PubMed ID: 2939944 [TBL] [Abstract][Full Text] [Related]
18. Effects of dehydroepiandrosterone on obesity and glucose-6-phosphate dehydrogenase activity in the lethal yellow mouse (strain 129/Sv-Ay/Aw). Granholm NH; Staber LD; Wilkin PJ J Exp Zool; 1987 Apr; 242(1):67-74. PubMed ID: 2955075 [TBL] [Abstract][Full Text] [Related]
19. Cancer prevention with dehydroepiandrosterone and non-androgenic structural analogs. Schwartz AG; Pashko LL J Cell Biochem Suppl; 1995; 22():210-7. PubMed ID: 8538200 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Verma AK; Garcia CT; Ashendel CL; Boutwell RK Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]